Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial

Mijin Kim, Jung Min Ahn, Do Yoon Kang, Min Ju Kim, Kyung Won Kim, Hyun Jung Koo, Dong Hyun Yang, Seung Chai Jung, Byungjun Kim, Yiu Tung Anthony Wong, Cheung Chi Simon Lam, Wei Hsian Yin, Jeng Wei, Yung Tsai Lee, Hsien Li Kao, Mao Shin Lin, Tsung Yu Ko, Won Jang Kim, Se Hun Kang, Seung Ah LeeEuihong Ko, Dae Hee Kim, Joon Won Kang, Jae Hong Lee, Jinho Lee, Jinsun Park, Hoyun Kim, Yeonwoo Choi, Seung Jung Park, Duk Woo Park

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science